CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04104776
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:48.309648+00:00
- Published At
- 2025-05-15T00:00:00+00:00
- Record Updated At
- 2025-05-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Solid Tumor", "Diffuse Large B Cell Lymphoma", "Lymphoma, T-Cell", "Mesothelioma, Malignant", "Prostatic Neoplasms, Castration-Resistant", "Endometrial Cancer", "Ovarian Clear Cell Carcinoma", "Metastatic Castration-resistant Prostate Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-15"- protocolSection.identificationModule.nctId
"NCT04104776"- protocolSection.identificationModule.officialTitle
"A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.